Drug Discovery World
OCTOBER 31, 2023
Interest in neurodegeneration amongst the public has increased in recent months due to several high-profile cases including rugby player Doddy Weir, who was diagnosed with motor neurone disease (MND) in 2016, and actor Bruce Willis, who was diagnosed with frontotemporal dementia (FTD) earlier this year.
Drug Target Review
JULY 4, 2023
The drivers behind the demand for ADCs Providing more targeted therapeutic options in the oncology space has underpinned the rapid growth of the ADC market; between 2016 to 2020, the US ADC market grew by 45 percent to a value of nearly $1.5 Petra holds a D.Phil in synthetic organic chemistry and am MBA from Imperial College London.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Agency IQ
SEPTEMBER 15, 2023
PFAS regulation in California (late 2023 edition) California consistently maintains its status as both one of the most important economies in the world as well as one of the most regulated states in the United States. In 2019, the state began to significantly ramp up its PFAS regulation and research.
Agency IQ
JULY 7, 2023
These carbon-fluorine bonds are some of the strongest in organic chemistry, meaning that most PFAS readily persist in the environment. Under the framework, new PFAS are expected to be considered persistent, bioaccumulative, and toxic (PBT) chemicals, which invokes another level of regulation for these future PFAS.
Drug Hunter
AUGUST 21, 2023
The BBB is composed of specialized brain endothelial cells that regulate the distribution of molecules into and out of the brain from the blood. Unlike the endothelial BBB, the blood-cerebrospinal fluid-barrier (BCSFB) is made up of epithelial cells that similarly regulate the distribution of molecules between the blood and CSF.
Expert insights. Personalized for you.
147 
Let's personalize your content